Digipath Inc
OTC:DIGP
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Digipath Inc
DigiPath, Inc. engages in the provision of cannabis testing, education, training, and news coverage. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2011-12-23. The Company’s cannabis testing business is operated through its subsidiary, Digipath Labs, Inc., which performs all cannabis related testing using FDA-compliant laboratory equipment and processes. The firm is a third-party independent testing laboratory facility for cannabis, cannabis infused products, hemp and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients and eventually all end users of cannabis and botanical products. Its Digipath Labs screens medicinal and recreational cannabis for harmful contaminants, including residual solvents, moisture, water activity, visual inspection, pesticides, heavy metals, biological toxins and microbial contaminants.
DigiPath, Inc. engages in the provision of cannabis testing, education, training, and news coverage. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2011-12-23. The Company’s cannabis testing business is operated through its subsidiary, Digipath Labs, Inc., which performs all cannabis related testing using FDA-compliant laboratory equipment and processes. The firm is a third-party independent testing laboratory facility for cannabis, cannabis infused products, hemp and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients and eventually all end users of cannabis and botanical products. Its Digipath Labs screens medicinal and recreational cannabis for harmful contaminants, including residual solvents, moisture, water activity, visual inspection, pesticides, heavy metals, biological toxins and microbial contaminants.
